Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.26% is 45% below its 5-year average of 5.88%, near the low end of its 5-year range (0.24%–19.46%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.65% below its 12-month average of 3.57%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.26%.
DEBT TO ASSETS RATIO
3.26%
DEBT TO ASSETS RATIO AVG TTM
3.57%
DEBT TO ASSETS RATIO AVG 3Y
2.53%
DEBT TO ASSETS RATIO AVG 5Y
5.88%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.65%
CURRENT VS 3Y AVG
+28.84%
CURRENT VS 5Y AVG
-44.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 663 covered companies
CURRENT VS SECTOR MEDIAN
+3158.44%
vs the sector median at left
iSpecimen Inc.
Market Cap
$2.63M
Debt to Assets Ratio
3.26%
TTM Avg
3.57%
3Y Avg
2.53%
5Y Avg
5.88%
Market Cap
$2.61M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.53M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.41M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.90M
Debt to Assets Ratio
0.77%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.33M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iSpecimen Inc. (ISPC) | $2.63M | 3.26% | 3.57% | 2.53% | 5.88% |
| Nuwellis, Inc. (NUWE)vs › | $2.61M | 0.02% | N/A | N/A | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.61M | 0.19% | N/A | N/A | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.67M | 0.49% | N/A | N/A | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.53M | 0.18% | N/A | N/A | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.41M | 0.01% | N/A | N/A | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.39M | 0.07% | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $2.90M | 0.77% | N/A | N/A | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.33M | 0.00% | N/A | N/A | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $2.95M | 0.01% | N/A | N/A | N/A |
Debt/Assets
3.3%
Debt/Equity
0.14
Current Ratio
0.82
Interest Coverage
-4606.4x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.26% |
| 2026-03-31 | 3.86% |
| 2025-12-31 | 2.82% |
| 2025-09-30 | 3.13% |
| 2025-06-30 | 4.77% |
| 2025-03-31 | 4.39% |
| 2024-12-31 | 3.34% |
| 2024-09-30 | 10.55% |
| 2024-06-30 | 0.24% |
| 2024-03-31 | 1.25% |
| 2023-12-31 | 1.24% |
| 2023-09-30 | 1.44% |
| 2023-06-30 | 0.61% |
| 2023-03-31 | 0.67% |
| 2022-12-31 | 0.75% |
| 2022-09-30 | 13.08% |
| 2022-06-30 | 12.64% |
| 2022-03-31 | 11.18% |
| 2021-12-31 | 9.58% |
| 2021-09-30 | 19.46% |
| 2021-06-30 | 15.30% |
| 2021-03-31 | 195.96% |
| 2020-12-31 | 205.61% |
| 2020-09-30 | 211.11% |
| 2019-12-31 | 251.31% |
